69 Best Biotechnology Startups to Watch in 2024

RNA-guided regulatory genome targeting therapeutics developer for chronic diseases.

Total Raised: $1018.00M

Last Funding: $1000.00M (Series D)

RNA-guided regulatory genome targeting therapeutics developer for chronic diseases.

Total Raised: $1000.00M

Last Funding: $1000.00M (Series D)

Comprehensively mapping and reprogramming the immune system with single-cell biology and AI to power new therapeutic discoveries, accelerate drug development and improve patient outcomes

Total Raised: $313.00M

Last Funding: $18.00M (Unknown)

Borealis Biosciences was founded on the premise that a convergence of scientific and translational breakthroughs is enabling the field of RNA medicines to treat kidney diseases and beyond. The company is backed by founding investor Versant Ventures and Novartis AG, and has a strategic collaboration with the pharma.

Total Raised: $150.00M

Last Funding: $150.00M (Series A)

TenNor Therapeutics specializes in research and development of new drugs for the treatment of digestive diseases

Total Raised: $66.00M

Last Funding: $41.00M (Series E)

Glooko provides innovative digital health solutions for diabetes and chronic conditions, simplifying tracking and data sharing for improved outcomes globally.

Total Raised: $112.50M

Last Funding: $100.00M (Series F)

Orasis Pharmaceuticals develops a corrective eye drop to treat presbyopia as an alternative to reading glasses.

Total Raised: $111.00M

Last Funding: $68.00M (Series D)

Noetik is an AI Cancer Immunotherapy Discovery.

Total Raised: $40.00M

Last Funding: $40.00M (Series A)

Kailera Therapeutics is a clinical-stage biotechnology company.

Total Raised: $400.00M

Last Funding: $400.00M (Series A)

Protembis is a cerebral Protection System founded in 2013.

Total Raised: $64.67M

Last Funding: $21.67M (Debt Financing)

PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology.

Total Raised: $20.70M

Last Funding: $20.70M (Series B)

ITM Isotopen Technologien Munchen is a Munich-based developer of personalized cancer diagnostic solutions.

Total Raised: $205.00M

Last Funding: $205.00M (Series D)

Be Biopharma is developing a proprietary class of engineered B cells as medicines in applications beyond cytotoxicity.

Total Raised: $264.00M

Last Funding: $82.00M (Unknown)

Formo is a manufacturer of animal-free cheese alternative products founded in 2019 by Raffael Wohlgensinger.

Total Raised: $111.70M

Last Funding: $61.00M (Series B)

Navigator Medicines operate as a biotech company.

Total Raised: $100.00M

Last Funding: $100.00M (Series A)

Cytovale is a company that develops biomarkers based on the mechanical properties of cells to identify diseases. It has applied its technology to detect sepsis.

Total Raised: $119.30M

Last Funding: $100.00M (Series D)

Formo is a manufacturer of animal-free cheese alternative products founded in 2019 by Raffael Wohlgensinger.

Total Raised: $111.50M

Last Funding: $45.80M (Series A)

Evommune is a biotechnology company that develops therapeutics that halt progressive disease and address their symptoms.

Total Raised: $198.00M

Last Funding: $115.00M (Series C)

Oral antifungal therapy developer to treat life-threatening rare fungal infections

Total Raised: $170.00M

Last Funding: $100.00M (Series D)

Purespring Therapeutics is a gene therapy provider for kidney diseases founded in 2020.

Total Raised: $155.00M

Last Funding: $105.00M (Series B)

Immune system-modulating technology platform for the treatment of cancer and autoimmune diseases.

Total Raised: $104.50M

Last Funding: $11.00M (Series C)

Moximed is a medical equipment manufacturing company that specializes in developing innovative solutions for osteoarthritis

Total Raised: $141.00M

Last Funding: $91.00M (Series D)

Nuclera is a provider of eProtein discovery benchtop system founded in 2013 by Jiahao Huang, Gordon McInroy and Michael Chen.

Total Raised: $117.50M

Last Funding: $75.00M (Series C)

Terray Therapeutics is a Los Angeles-based biotechnology company that combines ultra-high throughput experimentation, generative AI, biology, medicinal chemistry, automation, and nanotechnology to explore molecules and their targets for the purpose of discovering and developing small molecule therapeutics.

Total Raised: $180.00M

Last Funding: $120.00M (Series B)

ZAP Surgical Systems designs and manufactures the ZAP-X® radiosurgery platform.

Total Raised: $159.00M

Last Funding: $78.00M (Series E)

Developer of immunoglobulin E (IgE) antibodies to treat cancer.

Total Raised: $64.47M

Last Funding: $16.50M (Series B)

Alpha9 Theranostics is a biopharma company that focuses on radiotherapeutics for the treatment of solid and hematologic malignancies.

Total Raised: $127.75M

Last Funding: $127.75M (Series C)

IDRx is a clinical-stage biopharmaceutical company dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today’s precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy.

Total Raised: $120.00M

Last Funding: $120.00M (Series B)

Small molecule MKK4 inhibitors to treat acute and chronic liver diseases

Total Raised: $37.60M

Last Funding: $16.00M (Series C)

LoQus23 is a small molecule drugs developer for Huntington's disease founded in 2019 by David Reynolds.

Total Raised: $43.00M

Last Funding: $43.00M (Series A)

Developer of novel vaccines for respiratory viral infections.

Total Raised: $100.00M

Last Funding: $100.00M (Series B)

Judo Bio is a biotechnology company that develops precision therapeutics targeting specific cell populations to address genetic diseases.

Total Raised: $100.00M

Last Funding: $100.00M (Series A)

Gene therapies developer for pediatric patients.

Total Raised: $52.00M

Last Funding: $52.00M (Series B)

Lumicks is a drug discovery platform for cancer founded in 2014 by Gerrit Sitters .

Total Raised: $114.90M

Last Funding: $21.90M (Debt Financing)

Inbrain Neuroelectronics is a developer of brain-computer interface therapeutics (BCI-Tx founded in 2020 by Carolina Aguilar.

Total Raised: $68.10M

Last Funding: $50.00M (Series B)

Based on our deep science and focused on patients in need.

Total Raised: $112.00M

Last Funding: $112.00M (Series B)

MARAbio is a biotech firm that works to detect and prevent severe forms of Autism.

Total Raised: $19.00M

Last Funding: $19.00M (Series A)

Basecamp Research is an AI-driven protein sequences and biological systems developer founded in 2019 by Glen Gowers.

Total Raised: $80.00M

Last Funding: $60.00M (Series B)

PrognomiQ is a biotechnology firm that develops test products to detect early disease detection through the power of multi-omics data.

Total Raised: $80.00M

Last Funding: $34.00M (Series D)

Constructive Bio is a synthetic genome editing platform for biopharmaceuticals industry founded in 2021 by Jason Chin.

Total Raised: $73.00M

Last Funding: $58.00M (Series A)

InterVene is an up and coming medical device start-up company reinventing the way physicians treat severe venous disease in the legs.

Total Raised: $28.00M

Last Funding: $13.00M (Series A)

Nano syringe delivery platform.

Total Raised: $19.30M

Last Funding: $13.10M (Series A)

Focused on transforming lives of patients with immune dysfunctions and cancer

Total Raised: $386.00M

Last Funding: $168.00M (Series B)

Elicit Plant is a biosolutions provider for broadacre crops founded in 2017 by Jean-Francois Jeff Déchant.

Total Raised: $66.00M

Last Funding: $48.00M (Series B)

Blue Earth Therapeutics is a developer of radiotherapeutics to treat cancer patients founded in 2021.

Total Raised: $76.50M

Last Funding: $76.50M (Series A)

Alyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells.

Total Raised: $26.00M

Last Funding: $26.00M (Series A)

Indigo is an agricultural technology company utilizing natural microbiology and digital technologies to improve farmers' profitability, environmental sustainability and consumer health.

Total Raised: $620.50M

Last Funding: $175.00M (Series F)

Centaur Labs is a medical AI platform that offers medical data labeling services.

Total Raised: $16.15M

Last Funding: $16.00M (Series B)

Bright Uro’s mission is to revolutionize lower urinary tract symptoms (LUTS) care by building the next generation of diagnostic devices for Urology.

Total Raised: $38.00M

Last Funding: $32.00M (Series A)

Programming biolCellibre is a best-in-class manufacturing technology company.. Employing an organism-agnostic approach, we turn cells into specialized, sustainable factories for the manufacture of globally significant products at scale.ogy to turn cells into factories company

Total Raised: $18.21M

Last Funding: $6.71M (Unknown)

Brenus Pharma is a cancer vaccine developer founded in 2021 by Benoit Pinteur.

Total Raised: $29.50M

Last Funding: $25.00M (Series A)

CardiaTec is an AI-powered cardiovascular drug discovery platform founded in 2021 by Thelma Zablocki, Raphael Peralta and Namshik Han.

Total Raised: $8.20M

Last Funding: $6.50M (Seed)

Manufacturer of sensors for real-time monitoring of biological and chemical processes.

Total Raised: $7.37M

Last Funding: $6.80M (Seed)

Disco Pharmaceuticals is a cancer Surface Protein Identification founded in 2022.

Total Raised: $22.00M

Last Funding: $22.00M (Seed)

Naturbeads is a sustainable and biodegradable cellulose ingredients producer founded in 2018 by Giovanna Laudisio.

Total Raised: $11.59M

Last Funding: $9.85M (Series A)

Alchemy creates and implements clinical pharmacy programs and deploys technology products that use the pharmacy.

Total Raised: $31.00M

Last Funding: $31.00M (Seed)

Passkey Therapeutics is pioneering a new class of medicines, Synergistic Multifunctional Therapeutics (SMThs).

Total Raised: $20.00M

Last Funding: $20.00M (Seed)

Developer of a new class of proteasome activator medicines.

Total Raised: $15.00M

Last Funding: $15.00M (Seed)

Integrated Biosciences develops next-generation therapeutics.

Total Raised: $17.00M

Last Funding: $17.00M (Seed)

Somagenetix is a gene therapy developer for phagocyte disorders founded in 2019 by Ulrich Siler .

Total Raised: $11.66M

Last Funding: $11.66M (Series A)

Entosystem uses innovative insect farming technologies to position themselves as a dominant player in the circular agriculture economy.

Total Raised: $58.00M

Last Funding: $58.00M (Unknown)

Human genome sequencing company founded in 2013 and based in San Diego, CA. Human Longevity Inc. is building a database with genomic and phenotypic information and aims to make medicine more data-driven by combining DNA sequencing, expert analysis and machine learning

Total Raised: $39.80M

Last Funding: $39.80M (Series B)

TCR-based immunotherapies developer targeting novel dark antigens for cancer patients.

Total Raised: $32.50M

Last Funding: $32.50M (Series B)

Provider of tailor-made industrial solutions based on natural and genetically modified microorganisms.

Total Raised: $38.80M

Last Funding: $38.80M (Series B)

Provider of tailor-made industrial solutions based on natural and genetically modified microorganisms.

Total Raised: $38.80M

Last Funding: $38.80M (Series B)

Evoralis is a plastic-depolymerizing enzymes producer founded in 2021 by Liisa van Vliet , Josephin Holstein and Mariana Rangel Pereira.

Total Raised: $3.30M

Last Funding: $3.30M (Seed)

Epitopea is a RNA-based immunotherapies developer to treat cancer patients founded in 2021 by Jon Moore, Claude Perreault and Pierre Thibault.

Total Raised: $13.66M

Last Funding: $0.66M (Unknown)

Amphistar is a sustainable biosurfactant products producer founded in 2021 by Sophie Roelants , Bernd Everaert and Karolien Maes .

Total Raised: $8.50M

Last Funding: $2.20M (Unknown)

MiLaboratories is a bioinformatics solutions to probe adaptive immunity founded in 2021 by Stanislav Poslavsky.

Total Raised: $12.30M

Last Funding: $10.00M (Series A)